← 홈

IBD (크론·대장)

74개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 74개
AntibodystaleJanssenApproved

adalimumab (Humira, Infliximab Adalimumab y Golimumab)

Ulcerative Colitis; Thromboembolism · Ulcerative Colitis

#UlcerativeColitis#Antibody#Approved#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleJanssenApproved

Infliximab CT-P13 (Infliximab CT-P13)

Crohn Disease · Crohn Disease

#CrohnDisease#Antibody#Approved#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleJanssenApproved

Infliximab Dose Intensification (Infliximab Dose Intensification)

Crohn Disease (CD) · Crohn Disease (CD)

#CrohnDiseaseCD#Antibody#Approved#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleJanssenPhase 1

Infliximab Treatment (Infliximab Treatment)

Ulcerative Colitis Chronic Moderate; Ulcerative Colitis Chronic Severe · Ulcerative Colitis Chronic Moderate

#UlcerativeColitisChronicModerate#Antibody#Phase1#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleJanssenApproved

Infliximab and immunosuppressives (Infliximab and immunosuppressives)

Crohn Disease; Infliximab · Crohn Disease

#CrohnDisease#Antibody#Approved#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleJanssenPhase 3

Infliximab at weeks 0 and 8 (Infliximab at weeks 0 and 8)

Inflammatory Bowel Disease · Inflammatory Bowel Disease

#InflammatoryBowelDisease#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleJanssenPhase 3

Infliximab at weeks 0,2, and 6 (Infliximab at weeks 0,2, and 6)

Inflammatory Bowel Disease · Inflammatory Bowel Disease

#InflammatoryBowelDisease#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleJanssenPhase 3

Infliximab at weeks 0,4, and 8 (Infliximab at weeks 0,4, and 8)

Inflammatory Bowel Disease · Inflammatory Bowel Disease

#InflammatoryBowelDisease#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleJanssenPreclinical

Infliximab combined with azathioprine therapy (Infliximab combined with azathioprine therapy)

Crohn's Diseases; Crohn's Disease in Pediatric Patient · Crohn's Diseases

#CrohnsDiseases#Antibody#Preclinical#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleJanssenPreclinical

Infliximab monotherapy (Infliximab monotherapy)

Crohn's Diseases; Crohn's Disease in Pediatric Patient · Crohn's Diseases

#CrohnsDiseases#Antibody#Preclinical#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleJanssenApproved

ustekinumab (Stelara, Infliximab or adalimumab or golimumab or vedolizumab or ustekinumab or tofacitinib)

Inflammatory Bowel Diseases; Crohn Disease · Inflammatory Bowel Diseases

#InflammatoryBowelDiseases#Antibody#Approved#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleJanssenPhase 3

Infliximab precision dosing (Infliximab precision dosing)

Crohn Disease · Crohn Disease

#CrohnDisease#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleJanssenPhase 3

IIFX + AZA (Infliximab with azathioprine, Infliximab with azathioprine (IIFX + AZA))

Crohn Disease · Crohn Disease

#CrohnDisease#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleJanssenPreclinical

adalimumab (Humira, Infliximab, adalimumab, certolizumab pegol)

Inflammatory Bowel Disease; Crohn's Disease · Inflammatory Bowel Disease

#InflammatoryBowelDisease#Antibody#Preclinical#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleJanssenPreclinical

Infliximab-Dyyb (Infliximab-Dyyb)

Crohn's Disease · Crohn's Disease

#CrohnsDisease#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleJanssenApproved

Infliximab-Innovator (Infliximab-Innovator)

Colitis, Ulcerative; Crohn's Disease · Colitis, Ulcerative

#ColitisUlcerative#Antibody#Approved#항체#면역항체+5
임상시험 1상태 ACTIVE
AntibodystaleJanssenApproved

PRECISION dosing Infliximab (PRECISION dosing Infliximab)

Inflammatory Bowel Disease · Inflammatory Bowel Disease

#InflammatoryBowelDisease#Antibody#Approved#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleJanssenApproved

Palmitoleic Acid + Infliximab (Palmitoleic Acid + Infliximab)

Crohn's Disease · Crohn's Disease

#CrohnsDisease#Antibody#Approved#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleAsan Medical CenterApproved

Standard infliximab intravenous therapy (Standard infliximab intravenous therapy)

Crohn Disease; Infliximab · Crohn Disease

#CrohnDisease#Antibody#Approved#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleAbbVieApproved

adalimumab (Humira, Standard-Dose Adalimumab)

Crohn Disease (CD) · Crohn Disease (CD)

#CrohnDiseaseCD#Antibody#Approved#항체#면역항체+2
임상시험 1상태 RECRUITING

3 / 4 페이지

← 이전다음 →